P76.98 NSCLC Patients With Rare EGFR Mutations in Exons 18 and 19 Benefits From Treatment With EGFR Tyrosine Kinase Inhibitors J. Xu, R. Guo,M. Li, J. Xiang, A. Lizaso,X. Mao,J. Ye, C. Xu,K. ChenJournal of Thoracic Oncology（2021）引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
